a.kwiatkowski
TL2 Member · Valencia, ES
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 30 July 2025 · last posted 13h
84 posts, newest first. Showing up to 150.
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #20 · Start Here › How to Ask · 27 Jul 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #55 · Clinical › Prescriber conversations · 24 Jul 2026 · 3 likes This follows post #52 rather than contradicting it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
-
GLP-1 receptor distribution: central and peripheral Replied, post #96 · Pharmacology › Receptor biology · 23 Jul 2026 · 16 likes This follows post #93 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
An 18-month record including the parts that went badly Replied, post #72 · Outcomes › Progress reports · 17 Jul 2026 · 8 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Private prescribing in the UK: what is actually involved Replied, post #67 · Regional › UK & Ireland · 17 Jul 2026 · 20 likes Picking up post #64: that is the part I would want checked first. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #44 · Analytics › Method validation · 16 Jul 2026 · 0 likes post #43 answers the question as asked. The question underneath it is different. Accuracy: the method measures what you intend to measure. For purity methods, this is…
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #4 · Compounds › Retatrutide · 15 Jul 2026 · 2 likes This follows post #2 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #49 · Practice › Side effects · 14 Jul 2026 · 5 likes post #48 answers the question as asked. The question underneath it is different. Timeline matters: onset, duration, pattern over days or weeks, relationship to…
-
Follow-up: Reading an interaction checker output critically Replied, post #37 · Practice › Interactions · 8 Jul 2026 · 24 likes This follows post #34 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #40 · Documentation › Doc review · 7 Jul 2026 · 0 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
NHS criteria and how they are applied in practice Replied, post #13 · Regional › UK & Ireland · 27 Jun 2026 · 3 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Aggregate verification data across the directory, with caveats Replied, post #15 · Sourcing › Independent verification · 27 Jun 2026 · 1 like How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 0 likes Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. I have…
-
Batch numbers that do not match the vial label — what changed since Replied, post #37 · Sourcing › Red flags · 14 Jun 2026 · 24 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #44 · Analytics › Impurities & related substances · 12 Jun 2026 · 21 likes On post #40 — agreed on the reasoning, with one qualification. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
Micronutrient adequacy at low total intake Replied, post #63 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 16 likes Worth separating two things that post #59 runs together. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #40 · Practice › Administration · 11 Jun 2026 · 7 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
CJC-1295 with and without DAC: what the modification does Replied, post #80 · Compounds › Secretagogues & GH axis · 10 Jun 2026 · 4 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
The anatomy of a question that gets answered within an hour Replied, post #70 · Start Here › How to Ask · 7 Jun 2026 · 3 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Prescription portability between countries Replied, post #52 · Access › International · 3 Jun 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Why the cheapest option is often not the cheapest Replied, post #6 · Access › Pricing · 2 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #39 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Reading a trial's population section before its results Replied, post #24 · Evidence › Trials · 15 May 2026 · 1 like I read post #22 twice before replying, because I had assumed the opposite. Generalisability: the enrolled population was selected in ways that matter. Entry criteria,…
-
What to include when your question involves a chromatogram — one year on Replied, post #6 · Start Here › How to Ask · 15 May 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Request: show the solution author in the topic list — what changed since Replied, post #89 · Meta › Feature requests · 4 May 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #71 · Evidence › Trials · 3 May 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tracking intake honestly when appetite is absent Replied, post #11 · Nutrition & Training › Protein & intake · 29 Apr 2026 · 0 likes Worth separating two things that post #7 runs together. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #44 · Evidence › Journal club · 21 Apr 2026 · 29 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #16 · Research Methods › Statistics · 17 Apr 2026 · 24 likes On post #12 — agreed on the reasoning, with one qualification. Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of…
-
List price versus negotiated price versus what you pay Replied, post #77 · Access › Pricing · 14 Apr 2026 · 0 likes On post #73 — agreed on the reasoning, with one qualification. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an…
-
Fasting versus non-fasting and which tests care Replied, post #11 · Clinical › Bloodwork · 12 Apr 2026 · 6 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #38 · Start Here › Welcome · 9 Apr 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #3 · Compounds › Retatrutide · 22 Mar 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Mass and identity: a report on retatrutide should state the mass detected by LC-MS,…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #69 · Practice › Interactions · 16 Mar 2026 · 7 likes Picking up post #66: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #116 · Access › Pricing · 15 Mar 2026 · 21 likes This follows post #113 rather than contradicting it. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose,…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 22 Feb 2026 · 15 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #19 · Practice › Administration · 13 Feb 2026 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Angle of injection and whether 90 degrees is always right Replied, post #96 · Practice › Administration · 7 Feb 2026 · 27 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #46 · Practice › Storage & stability · 31 Jan 2026 · 13 likes Coming back to post #44, because the follow-up matters more than the original answer. Published stability data applies specifically to the formulation studied, under…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #9 · Compounds › Secretagogues & GH axis · 20 Jan 2026 · 0 likes This follows post #6 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #8 · marked as the solution · Analytics › Mass spectrometry · 13 Jan 2026 · 22 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Aggregates and why a purity assay may miss them entirely Replied, post #58 · Analytics › Impurities & related substances · 8 Jan 2026 · 1 like Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Personal import allowances, compared Replied, post #4 · Access › International · 18 Dec 2025 · 23 likes On post #2 — agreed on the reasoning, with one qualification. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #47 · Sourcing › Vendor reports · 18 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The decimal-point error, and the habit that catches it Replied, post #98 · Practice › Reconstitution · 18 Dec 2025 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
A history of disordered eating: proceeding carefully Replied, post #15 · Wellbeing › Mental health · 29 Nov 2025 · 22 likes post #14 answers the question as asked. The question underneath it is different. Identity and self-image: for some people, weight and body size are central to identity.…
-
How to ask about something you suspect is a bad idea Replied, post #29 · Start Here › How to Ask · 28 Nov 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Disagreeing with an answer you got: cite what you disagree with, say what…
-
Managing an unplanned gap in supply — what changed since Replied, post #125 · Access › Shortages · 24 Nov 2025 · 0 likes Worth separating two things that post #121 runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #46 · Wellbeing › Mental health · 5 Nov 2025 · 5 likes Picking up post #43: that is the part I would want checked first. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #23 · Analytics › Method validation · 2 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
New subcategory: rationale and scope Replied, post #131 · Meta › Announcements · 26 Oct 2025 · 23 likes Picking up post #128: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Payment mechanics and the recovery options that do not exist Replied, post #67 · Sourcing › Payments · 21 Oct 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 16 likes Worth separating two things that post #45 runs together. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #94 · Evidence › Preprints · 3 Oct 2025 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #27 · Clinical › Special populations · 26 Sep 2025 · 2 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Persistent vomiting and the threshold for seeking help Replied, post #37 · Safety › Adverse events · 20 Sep 2025 · 9 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.
-
Tracking that stops updating and then resumes Replied, post #23 · Sourcing › Logistics · 2 Sep 2025 · 13 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
How to research a compound with no human data without deceiving yourself Replied, post #24 · Compounds › Other compounds · 31 Jul 2025 · 23 likes I read post #22 twice before replying, because I had assumed the opposite. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not…
-
What a documentation review can and cannot tell you Replied, post #42 · Sourcing › Independent verification · 21 Jul 2025 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #164 · Practice › Reconstitution · 14 Jul 2025 · 0 likes This follows post #161 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #9 · Pharmacology › Receptor biology · 22 Jun 2025 · 28 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
System suitability injections: if they failed, the run did not happen Replied, post #6 · Analytics › HPLC & UHPLC · 9 Jun 2025 · 19 likes On post #2 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Asking about a compound your prescriber has not heard of Replied, post #56 · Clinical › Prescriber conversations · 3 Jun 2025 · 0 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Pre-registering a personal experiment, seriously Replied, post #43 · Research Methods › N-of-1 designs · 29 May 2025 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #53 · Compounds › Retatrutide · 27 May 2025 · 0 likes post #52 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #2 · Analytics › Method validation · 22 May 2025 · 12 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #129 · Sourcing › Independent verification · 21 May 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #19 · Analytics › Mass spectrometry · 8 May 2025 · 0 likes Worth separating two things that post #15 runs together. Resolution: "high resolution" commonly means
-
Adjudicated events and why the definition matters — the long version Replied, post #131 · Evidence › Trials · 2 May 2025 · 2 likes Worth separating two things that post #127 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
An emergency department visit, described afterwards Replied, post #14 · Safety › Adverse events · 24 Apr 2025 · 9 likes I read post #12 twice before replying, because I had assumed the opposite. Serious and unexpected events are the ones to document and report. Serious means…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #55 · Evidence › Journal club · 19 Apr 2025 · 12 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #18 · Compounds › Oral incretins · 14 Apr 2025 · 0 likes Picking up post #15: that is the part I would want checked first. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #8 · Evidence › Trials · 2 Apr 2025 · 2 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Telehealth prescribing models in the US Replied, post #71 · Regional › North America · 16 Mar 2025 · 6 likes This follows post #68 rather than contradicting it. Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #54 · Pharmacology › Receptor biology · 7 Mar 2025 · 5 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #27 · Analytics › COA interpretation · 25 Feb 2025 · 14 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Fixed versus detachable needles: the trade-offs Replied, post #111 · Devices › Syringes & needles · 14 Jan 2025 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Why "any advice?" is the least effective ending for a post Replied, post #80 · Start Here › How to Ask · 27 Nov 2024 · 32 likes On post #76 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and…
-
Food noise reducing and the disorientation that can follow Replied, post #41 · Wellbeing › Mental health · 15 Nov 2024 · 4 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Transit times by route, from a logged dataset — the long version Replied, post #25 · Sourcing › Logistics · 31 Oct 2024 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Meeting a protein target on a suppressed appetite — one year on Started this topic · Nutrition & Training › Protein & intake · 30 Aug 2024 · 16 likes Meeting a protein target on a suppressed appetite — one year on — setting out what I have, and where I think it stops being reliable. Longitudinal report with the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #166 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reporting a discrepancy without making an allegation Replied, post #23 · Sourcing › Vendor reports · 11 Aug 2024 · 17 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Coming back to: Grapefruit: why this class is not the class that cares Started this topic · Practice › Interactions · 9 Aug 2024 · 42 likes Posting this under the heading it deserves: Grapefruit: why this class is not the class that cares Everything below is what sits behind that. I have read the maintained…